Characterization of a novel polymorphic form of celecoxib

This publication has 17 references indexed in Scilit:

• The role of COX-2 inhibition in breast cancer treatment and prevention
  Seminars in Oncology, 2004
• High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids
  Advanced Drug Delivery Reviews, 2004
• Characterization of solid-state forms of celecoxib
  European Journal of Pharmaceutical Sciences, 2003
• Preparation and Characterization of Glassy Celecoxib
  Drug Development and Industrial Pharmacy, 2003
• The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
  New England Journal of Medicine, 2000
• Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib
  Clinical Pharmacokinetics, 2000
• Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects
  Arthritis & Rheumatism, 1998
• Inhibitory effects of water-soluble polymers on precipitation of RS-8359
  International Journal of Pharmaceutics, 1997
• Inhibitory effect of polyvinylpyrrolidone on the crystallization of drugs.
  Chemical and Pharmaceutical Bulletin, 1978
• Inhibition of Sulfathiazole Crystal Growth by Polyvinylpyrrolidone
  Journal of Pharmaceutical Sciences, 1970